ArticleNPJ digital medicine2026
Advanced breath analysis through hierarchical deep convolutional neural network for multi-cancer screening.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Editorial for the Special Issue "Applications of Biomedical Imaging and Sensing Technologies in Disease Diagnosis".Sensors (Basel, Switzerland) · 2026Article
- Real-Time Breath Diagnostics: Linking Molecular Pathways, Measurement Technologies, and Clinical Translation.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breath analysis offers a promising noninvasive strategy for early cancer detection by capturing disease-specific volatile organic compound (VOC) signatures in exhaled breath. In this study, we developed a hierarchical deep convolutional neural network (HD-CNN)-based platform for dual-cancer classification using a multimodal gas sensor array. Clinical breath samples were collected from 206 participants, including 67 healthy controls (HC), 78 lung cancer (LC), and 61 gastric cancer (GC) patients. The sensor array, composed of semiconductor metal oxide (SMO), electrochemical (EC), and photoionization detector (PID) sensors, generated time-resolved signals that were converted into 2D response maps for classification. The HD-CNN model employed a two-stage structure: a coarse classifier to distinguish HC from cancer patients (CP), followed by a fine classifier to separate LC and GC. In 5-fold cross-validation, the HD-CNN achieved classification accuracies of 82.1% (HC), 84.0% (LC), and 88.1% (GC), and average AUCs of 0.89, 0.92, and 0.89, respectively. Compared to a 1D CNN, the HD-CNN demonstrated superior class separability, increased prediction confidence, and overall enhanced performance. Additionally, we evaluated multiple coarse-fine configurations and found that isolating HC in the first stage resulted in the highest overall performance. These results support the utility of hierarchical learning and multimodal sensing for robust and scalable breath-based multi-cancer screening.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.